Methods useful in the treatment of bone resorption diseases
AssigneeNPS Allelix Corp.
InventorsJohn Dietrich, Sverker Ljunghall, Sven Sjögren
Life of this patent
Estimating the term…
Abstract
The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.
Claims29
A method useful in the treatment of bone resorption diseases comprising administering to a mammal in need of such treatment or at increased risk to suffer from such disease:
- (a) an effective amount of parathyroid hormone during a period of approximately 6 to 24 months;
- and
- (b) after the administration of parathyroid hormone has been terminated, an effective amount of a bone resorption inhibitor during a period of approximately 6 to 36 months.
Dependencies are inferred from the claim text.